Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
By T. Bale, A. Contarino, George W. Smith, Raymond K. W. Chan, L. Gold, P. Sawchenko, G. Koob, W. Vale, Kuo-Fen Lee. Nature Genetics, 2000
871 citations recorded by the source corpus.
Subfields: Behavioral Neuroscience, Biological Psychiatry, Social Psychology
View Paper: https://www.semanticscholar.org/paper/54dcb2cab0b0789e11cacbf557b2e74f895f0a09
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Behavioral Neuroscience
- Christine Marcelle Heim
- C. Nemeroff
- Bridget R. Mueller
- W. Craighead
- Gonzalo A. Carrasco
- M. Shugart
- S. Maier
- L. D. van de Kar
In Biological Psychiatry
- Christine Marcelle Heim
- C. Nemeroff
- Bridget R. Mueller
- T. Bale
- M. D. De Bellis
- Abigail Zisk A.B.
- Michael Joseph Meaney
- G. Koob
In Social Psychology
- Christine Marcelle Heim
- W. Craighead
- Gonzalo A. Carrasco
- M. Shugart
- C. Nemeroff
- S. Maier
- Linda R. Watkins
- L. D. van de Kar
Citations in the corpus
- The Corticosteroid Receptor Hypothesis of Depression (2000, background): “In contrast, CRH-R2 deficiency was shown to increase anxiety-like behavior in some (Bale et al. 2000; Kishimoto et al. 2000) but not all (Coste et al.”
- Sex-Specific Programming of Offspring Emotionality after Stress Early in Pregnancy (2008, methodology): “Audrey Seasholtz, University of Michigan, Ann Arbor, MI) or CRF probes as previously described (Bale et al., 2000).”
- Model organisms: The ascent of mouse: advances in modelling human depression and anxiety (2005, neutral): “The effectiveness of a test battery approach is further advocated by evidence that even among the ostensibly similar exploration-based mouse tasks, there are qualitative differences between tests, with each test measuring overlapping, but partially distinct, forms of anxiety-related behaviou”
- The Neurobiology of Parental Behavior (2003, background): “, 1999) and R2 knockouts manifest increased anxiety (Bale et al., 2000), neither genotype has been reported to show altered maternal behavior.”
- Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor (2001, background): “, whereas CRHR2 mediates stress-coping responses including anxiolysis, anorexia, hypotension, cardioprotection and dearousa”
- Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2 (2000, result): “Our results showing normal anxiety responses in Crhr2 −/− mice differ from those reported in an accompanying pape”
- Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. (2005, background): “However, these results could have been produced by developmental compensations, and indeed, Bale et al. (2000) found elevated levels of CRH and UCN in the genetically altered subjects.”
- Neuroendocrine pharmacology of stress. (2003, background): “Ten minutes after the onset of stress, corticosterone levels continued to rise in the CRF2 mutant mice reaching higher levels than in the wild type (Bale et al., 2000; Coste et al., 2000).”
- Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse (2000, background): “Mouse strains bearing targeted null mutations of CRF (Muglia et al., 1995), CRF-R1 (Smith et al., 1998), CRF-R2 (Bale et al., 2000; Coste et al., 2000; Kishimoto et al., 2000) and the CRF-binding protein (Karolyi et al., 1999) have been generated, and display phenotypes that have already begun to…”